Alan Beresford
Charles River Laboratories (United Kingdom)(GB)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods, Analytical Chemistry and Chromatography, Parkinson's Disease Mechanisms and Treatments, Epilepsy research and treatment
Most-Cited Works
- → Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4H-pyran-6-carboxamides(1998)340 cited
- → ADME/PK as part of a rational approach to drug discovery(2000)238 cited
- → The emerging importance of predictive ADME simulation in drug discovery(2002)236 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2012)161 cited
- → The Metabolism and Pharmacokinetics of Amlodipine in Humans and Animals(1988)159 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2013)123 cited
- → Metabolism and kinetics of amlodipine in man(1988)84 cited
- → Analysis of amlodipine in human plasma by gas chromatography(1987)80 cited
- → Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery(2006)71 cited
- → Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease(2015)61 cited